No Data
Earnings Preview: SPRO to Report Financial Results Post-market on November 14
$Spero Therapeutics(SPRO.US)$ is scheduled to release its financial results post-market on November 14 ET. Earnings PreviewAnalysts estimate $Spero Therapeutics(SPRO.US)$ to post revenue of USD7.67M
Spero Therapeutics to Report Third Quarter 2024 Financial Results and Provide Business Update on Thursday, November 14, 2024
H.C. Wainwright Maintains Spero Therapeutics(SPRO.US) With Buy Rating, Cuts Target Price to $5
Spero Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Express News | Spero Therapeutics, Inc. : H.c. Wainwright Cuts Target Price to $5 From $7
TD Cowen Maintains Spero Therapeutics(SPRO.US) With Buy Rating
No Data
No Data